Orthogonal Reversed-Phase C 18 and Pentafluorophenyl HPLC Separation for Phytochemical Profiling of Serrulatanes in Eremophila denticulata

Yong Zhao,Tuo Li,Louise Kjaerulff,Henrietta Venter,Sonia Coriani,Birger Lindberg Møller,Susan Semple,Dan Staerk
DOI: https://doi.org/10.1021/acs.jnatprod.3c00655
IF: 5.1
2023-11-27
Journal of Natural Products
Abstract:Serrulatanes constitute a class of unique diterpenoids derived from all-<i>Z</i> nerylneryl diphosphate rather than the conventional all-<i>E</i> diterpenoid precursor geranylgeranyl diphosphate and thus provide an intriguing expansion of the chemical space of plant specialized metabolites. Plants of the Australian <i>Eremophila</i> genus are rich sources of structurally diverse serrulatanes. Here, we report the identification of 15 hitherto undescribed serrulatanes (eremoculatanes A-N), together with 16 previously reported compounds, from the EtOAc extract of <i>Eremophila denticulata</i> leaves. Isolation was performed by a combined use of systematic HPLC-PDA-HRMS-based phytochemical profiling and orthogonal reversed-phase C<sub>18</sub> and pentafluorophenyl separations. Among the new compounds isolated, eremoculatane A contains a C<sub>12</sub> backbone, for which the configuration was established by comparison of experimentally measured and theoretically calculated ECD spectra. The antihyperglycemic and antibacterial activities of the <i>E. denticulata</i> extract were investigated by high-resolution inhibition profiling, and they indicated that major constituents, mainly serrulatanes and flavonoids, contributed to the observed activity of the extract. One flavonoid, eupafolin (<b>4</b>), displayed moderate α-glucosidase inhibitory activity with an IC<sub>50</sub> value of 41.3 μM, and four serrulatanes (<b>8</b>, <b>9</b>, <b>19g</b>, and <b>19j</b>) showed more than 50% PTP1B inhibition at 200 μM.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?